Look-back study on recipients of Parvovirus B19 (B19V) DNA-positive blood components

Vox Sanguinis

Volumn 109, Issue 4, 2015, Pages 305-311

  Juhl, David ^a   Ozdemir M ^a   Dreier, J ^b   Gorg S ^a   Hennig, H ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

B19V; Blood donors; Parvovirus B19 infection; Transfusion transmitted infection

Indexed keywords

FRESH FROZEN PLASMA; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; NEUTRALIZING ANTIBODY; THROMBOCYTE CONCENTRATE; VIRUS ANTIBODY; VIRUS DNA;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD COMPONENT; BLOOD DONOR; BLOOD TRANSFUSION; DISEASE COURSE; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA INFECTIOSUM; ERYTHROCYTE CONCENTRATE; HUMAN; HUMAN PARVOVIRUS B19; MALE; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RECIPIENT; SEQUENCE ANALYSIS; VIRUS TRANSMISSION; BLOOD; BLOOD COMPONENT THERAPY; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PARVOVIRUS INFECTION; TRANSMISSION;

ADULT; BASE SEQUENCE; BLOOD COMPONENT TRANSFUSION; BLOOD DONORS; DNA, VIRAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN;

EID: 84944278820     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12295     Document Type: Article

References (22)

1. Röhrer C, Gärtner B, Sauerbrei A, et al.: Seroprevalence of parvovirus B19 in the German population. Epidemiol Infect 2008; 136:1564-1575
2. Young NS, Brown KE: Parvovirus B19. N Engl J Med 2004; 350:586-597
3. Blümel J, Burger R, Drosten C, et al.: Parvovirus B19 - revised. Transfus Med Hemother 2010; 37:339-350
4. Juhl D, Steppat D, Görg S, et al.: Parvovirus B 19 (B19V) infections and blood counts in blood donors. Transfus Med Hemother 2014; 41:52-59
5. Parsyan A, Candotti D: Human erythrovirus B19 and blood transfusion - an update. Transfus Med 2007; 17:263-278
6. Food and Drug Administration: Nucleic Acid Testing (NAT) to Reduce the Possible Risk of Human Parvovirus B19 Transmission by Plasma-Derived Products. Available at: http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/ucm078510.pdf (accessed on 2015 May 18)
7. Kleinman SH, Glynn SA, Lee TH, et al.: A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusion. Blood 2009; 114:3677-3683
8. Yu MY, Alter HJ, Virata-Theimer ML, et al.: Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples. Transfusion 2010; 50:1712-1721
9. Satake M, Hoshi Y, Taira R, et al.: Symptomatic parvovirus B19 infection caused by blood component transfusion. Transfusion 2011; 51:1887-1895
10. Hourfar MK, Mayr-Wohlfart U, Themann A, et al.: Recipients potentially infected with parvovirus B19 by red blood cell products. Transfusion 2011; 51:129-136
11. Lefrère JJ, Servant-Delmas A, Candotti D, et al.: Persistent B19 infection in imm-unocompetent individuals: Implications for transfusion safety. Blood 2005; 106:2890-2895
12. Matsukura H, Shibata S, Tani Y, et al.: Persistent infection by human parvovirus B19 in qualified blood donors. Transfusion 2008; 48:1036-1037
13. Juhl D, Görg S, Hennig H: Persistence of Parvovirus B19 (B19V) DNA and humoral immune response in B19V-infected blood donors. Vox Sang 2014; 107:226-232
14. Schmidt M, Themann A, Drexler C, et al.: Blood donor screening for parvovirus B19 in Germany and Austria. Transfusion 2007; 47:1775-1782
15. Hokynar K, Brunstein J, Söderlund-Venermo M, et al.: Integrity and full coding sequence of B19 virus DNA persisting in human synovial tissue. J Gen Virol 2000; 81:1017-1025
16. Molenaar-de Backer MW, Lukashov VV, van Binnendijk RS, et al.: Global co-existence of two evolutionary lineages of parvovirus B19 1a, different in genome-wide synonymous positions. PLoS One 2012; 7:e43206
17. Servant-Delmas A, Laperche S, Mercier M, et al.: Limits of sequencing and phylogenetic analysis to assess B19V transmission by single-donor blood component. Vox Sang 2011; 100:254-255
18. Daly P, Corcoran A, Mahon BP, et al.: High-sensitivity PCR detection of parvovirus B19 in plasma. J Clin Microbiol 2002; 40:1958-1962
19. Modrof J, Berting A, Tille B, et al.: Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins. Transfusion 2008; 48:178-186
20. Anderson MJ, Higgins PG, Davis LR, et al.: Experimental parvoviral infection in humans. J Infect Dis 1985; 152:257-265
21. Ziemann M, Juhl D, Görg S, et al.: The impact of donor cytomegalovirus DNA on transfusion strategies for at-risk patients. Transfusion 2013; 53:2183-2189
22. Klein HG: Transfused B19V: B-nign, B-ware, B-gone? Blood 2009; 114:3509-3511